ONC Q4 2018 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$32B

Q4 2018 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$59M+222.8% YoY

Gross Profit

-$208M-354.5% margin

Operating Income

-$281M-478.6% margin

Net Income

-$268M-457.2% margin

EPS (Diluted)

$-4.55

QoQ Revenue Growth

+8.2%

Cash Flow

Operating Cash Flow

-$194M

Free Cash Flow

-$277M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$2.2B

Total Liabilities

$496M

Stockholders' Equity

$1.8B

Cash & Equivalents

$713M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$59M	$18M	+222.8%
Gross Profit	-$208M	-$76M	-173.0%
Operating Income	-$281M	-$104M	-170.5%
Net Income	-$268M	-$99M	-170.1%